Showing 1 - 1 results of 1 for search 'Michael J. Lamson, PhD', query time: 0.02s
Refine Results
-
1
A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector by David A. Dworaczyk, PhD, Allen L. Hunt, MD, Mike Di Spirito, MSc, Mary Lor, BSc, GrDip, Kenneth L. Dretchen, PhD, Michael J. Lamson, PhD, Jonathan Pollock, MSci, Thelma Ward, PhD
Published 2024-05-01
Article